A study evaluating impact of baseline protease minority resistant variants on virological response to a protease inhibitor based regimens.
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Atazanavir (Primary) ; Darunavir (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 02 Nov 2017 New trial record
- 25 Oct 2017 Results published in the Journal of Antimicrobial Chemotherapy